论文部分内容阅读
目的观察评价胃癌术后序贯性早期肠内营养支持的临床效果及卫生经济学效益。方法随机选取医院2016年1月~2017年1月收治的76例胃癌患者为本次实验研究对象,按照早期肠内营养支持方式不同将所有患者均分为实验组与对照组,对照组38例患者给予非序贯性早期肠内营养支持,实验组38例患者给予序贯性早期肠内营养支持,比较两组患者临床治疗效果以及卫生经济学效益。结果实验组患者术后喂养不耐受临床症状量表显示不耐受率明显低于对照组,实验组有3例患者出现不良反应,对照组有6例患者出现不良反应,实验组患者成本、效果指数、成本效果比明显优于对照组,两组患者数据差异明显,具有统计学意义(P<0.O5)。结论对于胃癌手术后患者给予序贯性早期肠内营养支持能有效降低患者喂养不耐受和不良反应发生率,提高患者成本效果比,值得推广。
Objective To evaluate the clinical efficacy and health economics benefit of sequential sequential enteral nutrition support after gastric cancer surgery. Methods A total of 76 patients with gastric cancer admitted from January 2016 to January 2017 in our hospital were selected as the experimental subjects. All patients were divided into experimental group and control group according to the different enteral nutrition support methods. 38 cases in control group Patients were given non-sequential early enteral nutrition support, and 38 patients in the experimental group were given sequential early enteral nutrition support. The clinical efficacy and health economics benefit were compared between the two groups. Results In the experimental group, the clinical symptoms scale of feeding intolerance after operation showed that the rate of intolerance was significantly lower than that of the control group. There were 3 adverse reactions in the experimental group and 6 patients in the control group. The cost, The effect index and the cost-effectiveness ratio were significantly better than those of the control group. There was significant difference between the two groups of patients with statistical significance (P <0.O5). Conclusion Sequential early enteral nutrition support for patients with gastric cancer after surgery can effectively reduce the incidence of feeding intolerance and adverse reactions and improve the cost-effectiveness of patients, which is worthy of promotion.